TRPA1 and cancer: Chemotherapeutic agents like cyclophosphamide and ifosfamide for cancer, severe arthritis, multiple sclerosis, and lupus [62, 149] generate acrolein as a metabolite, suggesting that TRPA1 may be involved in the side effects of such conditions.